Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 27;10(11):2354.
doi: 10.3390/jcm10112354.

Outcomes Related to Percutaneous Nephrostomies (PCN) in Malignancy-Associated Ureteric Obstruction: A Systematic Review of the Literature

Affiliations
Review

Outcomes Related to Percutaneous Nephrostomies (PCN) in Malignancy-Associated Ureteric Obstruction: A Systematic Review of the Literature

Francesca J New et al. J Clin Med. .

Abstract

Background: Malignant ureteric obstruction occurs in a variety of cancers and has been typically associated with a poor prognosis. Percutaneous nephrostomy (PCN) can potentially help increase patient longevity by establishing urinary drainage and treating renal failure. Our aim was to look at the outcomes of PCN in patients with advanced cancer and the impact on the patients' lifespan and quality of life.

Materials and methods: A literature review was carried out for articles from 2000 to 2020 on PCN in patients with advanced malignancies, using MEDLINE, EMBASE, Scopus, CINAHL, Cochrane Library, clinicaltrials.gov, and Google Scholar. All English-language articles reporting on a minimum of 20 patients who underwent PCN for malignancy-associated ureteric obstruction were included.

Results: A total of 21 articles (1674 patients) met the inclusion criteria with a mean of 60.2 years (range: 21-102 years). PCN was performed for ureteric obstruction secondary to urological malignancies (n = -633, 37.8%), gynaecological malignancies (n = 437, 26.1%), colorectal and GI malignancies (n = 216, 12.9%), and other specified malignancies (n = 205, 12.2%). The reported mean survival times varied from 2 to 8.5 months post PCN insertion, with an average survival time of 5.6 months, which depended on the cancer type, stage, and previous treatment.

Conclusions: Patients with advanced malignancies who need PCN tend to have a survival rate under 12 months and spend a large proportion of this time in the hospital. Although the advent of newer chemotherapy and immunotherapy options has changed the landscape of managing advanced cancer, decisions on nephrostomy must be balanced with their survival and quality of life, which must be discussed with the patient.

Keywords: decision making; nephrostomy; prostate cancer; quality of life; survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interests.

Figures

Figure 1
Figure 1
PRISMA flowchart of the included articles.
Figure 2
Figure 2
(A): Patients who died on the same admission as nephrostomy (PCN) insertion (B): Median survival post PCN insertion.

References

    1. Bigum L.H., Spielmann M.E., Juhl G., Rasmussen A. A qualitative study exploring male cancer patients’ experiences with percutaneous nephrostomy. Scand. J. Urol. 2014;49:162–168. doi: 10.3109/21681805.2014.938694. - DOI - PubMed
    1. Kouba E., Wallen E.M., Pruthi R.J. Management of ureteral obstruction due to advanced malignancy: Optimising therapeutic and palliative outcomes. J. Urol. 2008;180:444–450. doi: 10.1016/j.juro.2008.04.008. - DOI - PubMed
    1. Radecka E., Magnusson A. Complications associated with percutaneous nephrostomies. A retrospective study. Acta Radiol. 2004;45:184–188. doi: 10.1080/02841850410003671. - DOI - PubMed
    1. Wah T.M., Weston M.J., Irving H.C. Percutaneous nephrostomy insertion: Outcome data from a prospective multi-operator sudy at a UK training centre. Clin. Radiol. 2004;59:255–261. doi: 10.1016/j.crad.2003.10.021. - DOI - PubMed
    1. Patel U., Hussain F.F. Percutaneous Nephrostomy of Nondilated Renal Collecting Systems with Fluoroscopic Guidance: Technique and Results. Radiology. 2004;233:226–233. doi: 10.1148/radiol.2331031342. - DOI - PubMed

LinkOut - more resources